The life cycle of Kaposi's sarcoma-associated herpesvirus (KSHV) consists of two phases,
latent and lytic. The virus establishes latency as a strategy for avoiding host immune …

The linkage of Kaposi sarcoma (KS) to infection by a novel human herpesvirus (Kaposi
sarcoma–associated herpesvirus [KSHV]) is one of the great successes of contemporary …

This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

Kaposi's sarcoma (KS) has long been suspected of having an infectious etiology on the
basis of its unusual epidemiology, histopathology, and natural history. Nearly a decade ago …

Kaposi's sarcoma-associated herpesvirus (KSHV) establishes a latent infection in the host
following an acute infection. Reactivation from latency contributes to the development of …

The recently identified human herpesvirus 8 (HHV-8, or Kaposi's sarcoma-associated
herpesvirus) has been implicated in the etiology of both Kaposi's sarcoma (KS) and primary …

Objective: To evaluate the clinical and biological impact of protease inhibitors on HIV-
associated Kaposi's sarcoma. Design and setting: A cohort of 10 patients included …

Kaposi's sarcoma (KS) is an angioproliferative disease occurring in 4 clinic-epidemiologic
forms. Although the AIDS-associated KS (AIDS-KS) is the most aggressive, all forms of KS …

Patients with Kaposi's sarcoma (KS) have a human herpesvirus-8 (HHV-8) load higher than
patients without KS and present a CD8+ T-cell activation with production of Th1-type …

Background: The finding of antibodies against human herpesvirus 8 (HHV-8) is associated
with the occurrence of Kaposi's sarcoma in persons infected with HIV. However, the …